Cardiovascular risk in women with diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 6, 2010, Pages 474-480

  Rivellese, A A ^a   Riccardi, G ^a   Vaccaro, O ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular disease; Cardiovascular disease risk factors management; Diabetes mellitus; Gender

Indexed keywords

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEX DIFFERENCE; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS; WOMEN'S HEALTH;

EID: 77954955184     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.01.008     Document Type: Review

References (47)

1. Laing S.P., Swerdlow A.J., Slater S.D., Burden A.C., Morris A., Waugh N.R., et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 760-765.
2. Soedamah-Muthu S.S., Chaturvedi N., Toeller M., Ferriss B., Reboldi P., Michel G., et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe. The EURODIAB prospective complications study. Diabetes Care 2004, 27(2):530-537.
3. Huxley R., Barzi F., Woodward M. Excess risk associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332:73-78.
4. Orchard T.J. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin dependent diabetes mellitus. Ann Med 1996, 28:323-333.
5. Lee W.I., Cheung A.M., Cape D., Zinman B. Impact of diabetes on coronary heart disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000, 23:962-968.
6. Kanaya A., Grady D., Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus. Arch Intern Med 2002, 1737-1745.
7. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
8. Juutilainen A., Kortelainen S., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004, 27(12):2898-2904.
9. Crowley A., Menon V., Lessard D., Yarzebsky J., Jackson E., Gore J.M., et al. Sex difference in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester heart attack study). Am Heart J 2003, 146:824-831.
10. The task force on diabetes and cardiovascular diseases of the ESC and of the EASD. Guidelines on diabetes, pre-diabetes, and cardiovascular disease. Eur Heart J 2007, (Suppl. C).
11. Sander D., Sander K., Poppert H. Stroke in diabetes. Br J Diabetes Vasc Dis 2008, 8:222-229.
12. Mulnier H.E., Searman H.E., Raleih V.S., Soedamah-Muthu S.S., Colhoun H.M., Lawrenson R.A., et al. Risk of stroke in people with type 2 diabetes in the UK: a study using the general practice research database. Diabetologia 2006, 49:2859-2865.
13. Kannel W.B., McGee D.L. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979, 59:8-13.
14. Gregg E., Gu Q., Cheng Y.J., Narayan V., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007, 147:149-155.
15. Barengo N.C., Katos S., Moltchanov V., Tajima N., Tuomiletho J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J 2008, 29(15):1989-1995.
16. Rosner Preis S., Hwand S.J., Coady S., Pencina M.J., D'agostino R.B., Savage P.J. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation 2009, 119:1728-1733.
17. Dale A.C., Vatten L., Nilsen T.I., Midthiell K., Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 2008, 337:99-102.
18. Cartensen B., Kristensen J.K., Ottosen P., Borch-Johnsen K. The Danish national diabetes register: trends in incidence, prevalence and mortality. Diabetologia 2008, 51:2187-2196.
19. Lipscombe L., Hux E.J. Trends in diabetes prevalence, incidence and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
20. Legato J., Gelzer A., Goland R., Ebner S.A., Rajan S., Villagra V., et al. Gender-specific care of the patients with diabetes: review and recommendations. Gend Med 2006, 3(2):131-158. The Writing Group for the Partnership for Gender-Specific Medicine.
21. Flegal M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
22. Bassuk S., Manson J.A. Gender and its impact on risk factors for cardiovascular disease. Principles of gender-specific medicine 2004, vol. 1:193-214. Elsevier academic Press, San Diego, CA. M.J. Legato (Ed.).
23. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., Lee E.T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998, 21(8):1258-1265.
24. Vaccaro O., Boemi M., Cavalot F., De Feo P., Miccoli R., Patti L., et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis 2008, 198:396-402. The Mind-It Study Group.
25. Franklin S.S. Definition and epidemiology of hypertensive cardiovascular disease in women: the size of the problem. J Hypertens Suppl 2002, 20:S3-S5.
26. Hypertension in Diabetes Study. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993, 11(3):309-317. The Hypertension Study Group.
27. Glynn R.J., L'Italien G.J., Sesso H.D., Jackson E.A., Buring J.E. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002, 39(1):105-110.
28. Fruchart J.C., Sachs F.M., Hermans M.P., Assmann G., Brown W.V., Ceskea R., et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008, 102:1K-34K.
29. Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Non fasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308.
30. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46:733-749.
31. Barrett-Connor E., Giardina E.G.V., Gitt A.K., Gudat U., Steinberg H.O., Tschoepe D. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med 2004, 164(9):934-942.
32. Walden C.E., Knopp M.S.R.H., Wahl P.W., Beach K.W., Strandness E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984, 311(15):953-959.
33. Goldschmid M.G., Barrett-Connor E., Eldstein S.L., Wingard D.L., Cohn B.A., Herman W.H. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994, 89(3):991-997.
34. UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997, 20:1683-1687.
35. Haffner S.M., Mykkänen L., Stern M.P., Paidi M., Howard B.V. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994, 17(10):1164-1171.
36. Barrett-Connor E., Grundy S.M., Halbrook J.J. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 1982, 115(5):657-663.
37. Evans R.W., Orchard T.J. Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction?. Metabolism 1994, 43:1196-1200.
38. Knopp R.H., Paramsothy P., Retzlaff B.M., Fish B., Walden C., Dowdy A., et al. Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Atheroscler Rep 2005, 472-479.
39. Chan P., Pan W.H. Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients. Diabet Med 1995, 12:504-507.
40. Lapice M., Maione S., Patti L., Cipriano P., Rivellese A.A., Riccardi G., et al. Diabetes Care 2009, 32:1734-1736.
41. Steinberg H.O., Paradisi G., Cronin J., Crowde K., Hempfling A., Hook G., et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000, 101(17):2040-2046.
42. Ferrara A., Mangione C.M., Kim C., Marrero D.G., Curb D., Stevens M. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes. Diabetes Care 2008, 31:69-74.
43. Fremont A.M., Correra-de-Araujo R., Hayes S. Gender disparities in managed care it's time for action. Womens Health Issues 2007, 17:116-119.
44. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008, 371:117-123. Cholesterol Treatment Trialists' (CTT) Collaborators.
45. Rabi D.M., Khan N., Vallee M., Hladunewich, Tobe S.W., Pilote L. Reporting on sex-based analysis in clinical trials of angiotensin converting enzyme inhibitor and angiotensin receptor blocker efficacy. Can J Cardiol 2008, 24:491-496.
46. De Berardis G., Sacco M., Graziano G., Pellegrini F., Nicolucci A. Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis of randomized controlled trials. Diabetes 2009, 58(1):A24.
47. Silander K., Alanne M., Kristianson K., Saarela O., Ripatti S., Auro K. Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE 2008, 3(10):e3615.